Increasing Engagement in PTSD Treatment Through Patient Education and Patient Choice
NCT ID: NCT01446146
Last Updated: 2013-07-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
27 participants
INTERVENTIONAL
2011-10-31
2013-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Facilitating Transition to Recommended PTSD Treatment
NCT05165940
The Effects of a Psychoeducational Intervention on Health and Performance-based Outcomes of Veterans Diagnosed With PTSD
NCT06403514
Teaching Loved Ones to Help Veterans Optimize Their PTSD Care and Healing
NCT04241094
Peer-Delivered Whole Health Coaching for Veterans With PTSD
NCT03364192
An Adjunctive Family Intervention for Individual Posttraumatic Stress Disorder Treatment
NCT02956434
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
IDM intervention
Will receive a 40 minute intervention session with a clinician, learning about PTSD treatment options and choosing a preferred treatment.
Informed decision making
40 minute session with a clinician. Participants will learn about the available PTSD treatment options and will be given a decision aid with more information.
Treatment as usual plus placebo session
Will work with provider to select a treatment plan and will receive a 40 minute session without IDM intervention.
Placebo session
Participant will complete clinician-administered measures in a 40-minute session.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Informed decision making
40 minute session with a clinician. Participants will learn about the available PTSD treatment options and will be given a decision aid with more information.
Placebo session
Participant will complete clinician-administered measures in a 40-minute session.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Newly enrolled in Trauma Recovery Program (TRP) at the Michael E. DeBakey VA medical center
* TRP provider approval
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
South Central VA Mental Illness Research, Education & Clinical Center
FED
Michael E. DeBakey VA Medical Center
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Juliette Mott
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Juliette M Mott, PhD
Role: PRINCIPAL_INVESTIGATOR
MDVAMC, BCM, SC MIRECC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Michael E. DeBakey VA Medical Center
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-28111
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.